Back to Search
Start Over
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye.
- Source :
-
Clinical immunology (Orlando, Fla.) [Clin Immunol] 2022 Mar; Vol. 236, pp. 108951. Date of Electronic Publication: 2022 Feb 05. - Publication Year :
- 2022
-
Abstract
- Erythroblastic synartesis is a rare cause of acquired dyserythropoiesis. Only 9 cases have been previously reported. We hereby report 3 cases of patients diagnosed with erythroblastic synartesis associated with monoclonal immunoglobulin and an overt malignant lymphoid disorder. A different B-cell clone may produce the monoclonal immunoglobulin, forming a biclonal disorder. In light of these data and literature review, treatment targeting the paraprotein seems to be efficient to control synartesis and correct anemia. In the case of monoclonal gammapathy associated with chronic lymphocytic leukemia, therapeutics should be adapted to control both chronic lymphocytic leukemia and monitored monoclonal immunoglobulin titer.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1521-7035
- Volume :
- 236
- Database :
- MEDLINE
- Journal :
- Clinical immunology (Orlando, Fla.)
- Publication Type :
- Academic Journal
- Accession number :
- 35134549
- Full Text :
- https://doi.org/10.1016/j.clim.2022.108951